Global Brugada Syndrome Market Growth (Status and Outlook) 2022-2028
- LP 4759471
- 85 Pages
- January 2022
- Pharmaceuticals
The United States Brugada Syndrome market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Brugada Syndrome market, reaching US$ million by the year 2028. As for the Europe Brugada Syndrome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Brugada Syndrome players cover GeneDx, PGxHealth, GE Healthcare, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Brugada Syndrome market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Diagnosis
Treatment
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adult
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GeneDx
PGxHealth
GE Healthcare
Pfizer
Abbott
Medtronic
Boston Scientific
GlaxoSmithKline
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brugada Syndrome Market Size 2017-2028
2.1.2 Brugada Syndrome Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Brugada Syndrome Segment by Type
2.2.1 Diagnosis
2.2.2 Treatment
2.3 Brugada Syndrome Market Size by Type
2.3.1 Brugada Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Brugada Syndrome Market Size Market Share by Type (2017-2022)
2.4 Brugada Syndrome Segment by Application
2.4.1 Adult
2.4.2 Child
2.5 Brugada Syndrome Market Size by Application
2.5.1 Brugada Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Brugada Syndrome Market Size Market Share by Application (2017-2022)
3 Brugada Syndrome Market Size by Player
3.1 Brugada Syndrome Market Size Market Share by Players
3.1.1 Global Brugada Syndrome Revenue by Players (2020-2022)
3.1.2 Global Brugada Syndrome Revenue Market Share by Players (2020-2022)
3.2 Global Brugada Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Brugada Syndrome by Regions
4.1 Brugada Syndrome Market Size by Regions (2017-2022)
4.2 Americas Brugada Syndrome Market Size Growth (2017-2022)
4.3 APAC Brugada Syndrome Market Size Growth (2017-2022)
4.4 Europe Brugada Syndrome Market Size Growth (2017-2022)
4.5 Middle East & Africa Brugada Syndrome Market Size Growth (2017-2022)
5 Americas
5.1 Americas Brugada Syndrome Market Size by Country (2017-2022)
5.2 Americas Brugada Syndrome Market Size by Type (2017-2022)
5.3 Americas Brugada Syndrome Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brugada Syndrome Market Size by Region (2017-2022)
6.2 APAC Brugada Syndrome Market Size by Type (2017-2022)
6.3 APAC Brugada Syndrome Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Brugada Syndrome by Country (2017-2022)
7.2 Europe Brugada Syndrome Market Size by Type (2017-2022)
7.3 Europe Brugada Syndrome Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Brugada Syndrome by Region (2017-2022)
8.2 Middle East & Africa Brugada Syndrome Market Size by Type (2017-2022)
8.3 Middle East & Africa Brugada Syndrome Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Brugada Syndrome Market Forecast
10.1 Global Brugada Syndrome Forecast by Regions (2023-2028)
10.1.1 Global Brugada Syndrome Forecast by Regions (2023-2028)
10.1.2 Americas Brugada Syndrome Forecast
10.1.3 APAC Brugada Syndrome Forecast
10.1.4 Europe Brugada Syndrome Forecast
10.1.5 Middle East & Africa Brugada Syndrome Forecast
10.2 Americas Brugada Syndrome Forecast by Country (2023-2028)
10.2.1 United States Brugada Syndrome Market Forecast
10.2.2 Canada Brugada Syndrome Market Forecast
10.2.3 Mexico Brugada Syndrome Market Forecast
10.2.4 Brazil Brugada Syndrome Market Forecast
10.3 APAC Brugada Syndrome Forecast by Region (2023-2028)
10.3.1 China Brugada Syndrome Market Forecast
10.3.2 Japan Brugada Syndrome Market Forecast
10.3.3 Korea Brugada Syndrome Market Forecast
10.3.4 Southeast Asia Brugada Syndrome Market Forecast
10.3.5 India Brugada Syndrome Market Forecast
10.3.6 Australia Brugada Syndrome Market Forecast
10.4 Europe Brugada Syndrome Forecast by Country (2023-2028)
10.4.1 Germany Brugada Syndrome Market Forecast
10.4.2 France Brugada Syndrome Market Forecast
10.4.3 UK Brugada Syndrome Market Forecast
10.4.4 Italy Brugada Syndrome Market Forecast
10.4.5 Russia Brugada Syndrome Market Forecast
10.5 Middle East & Africa Brugada Syndrome Forecast by Region (2023-2028)
10.5.1 Egypt Brugada Syndrome Market Forecast
10.5.2 South Africa Brugada Syndrome Market Forecast
10.5.3 Israel Brugada Syndrome Market Forecast
10.5.4 Turkey Brugada Syndrome Market Forecast
10.5.5 GCC Countries Brugada Syndrome Market Forecast
10.6 Global Brugada Syndrome Forecast by Type (2023-2028)
10.7 Global Brugada Syndrome Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GeneDx
11.1.1 GeneDx Company Information
11.1.2 GeneDx Brugada Syndrome Product Offered
11.1.3 GeneDx Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GeneDx Main Business Overview
11.1.5 GeneDx Latest Developments
11.2 PGxHealth
11.2.1 PGxHealth Company Information
11.2.2 PGxHealth Brugada Syndrome Product Offered
11.2.3 PGxHealth Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 PGxHealth Main Business Overview
11.2.5 PGxHealth Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare Brugada Syndrome Product Offered
11.3.3 GE Healthcare Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Brugada Syndrome Product Offered
11.4.3 Pfizer Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Brugada Syndrome Product Offered
11.5.3 Abbott Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Medtronic
11.6.1 Medtronic Company Information
11.6.2 Medtronic Brugada Syndrome Product Offered
11.6.3 Medtronic Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Medtronic Main Business Overview
11.6.5 Medtronic Latest Developments
11.7 Boston Scientific
11.7.1 Boston Scientific Company Information
11.7.2 Boston Scientific Brugada Syndrome Product Offered
11.7.3 Boston Scientific Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Boston Scientific Main Business Overview
11.7.5 Boston Scientific Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Brugada Syndrome Product Offered
11.8.3 GlaxoSmithKline Brugada Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
12 Research Findings and Conclusion
Table 1. Brugada Syndrome Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diagnosis
Table 3. Major Players of Treatment
Table 4. Brugada Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Brugada Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Brugada Syndrome Market Size Market Share by Type (2017-2022)
Table 7. Brugada Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Brugada Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Brugada Syndrome Market Size Market Share by Application (2017-2022)
Table 10. Global Brugada Syndrome Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Brugada Syndrome Revenue Market Share by Player (2020-2022)
Table 12. Brugada Syndrome Key Players Head office and Products Offered
Table 13. Brugada Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Brugada Syndrome Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Brugada Syndrome Market Size Market Share by Regions (2017-2022)
Table 18. Americas Brugada Syndrome Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Brugada Syndrome Market Size Market Share by Country (2017-2022)
Table 20. Americas Brugada Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Brugada Syndrome Market Size Market Share by Type (2017-2022)
Table 22. Americas Brugada Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Brugada Syndrome Market Size Market Share by Application (2017-2022)
Table 24. APAC Brugada Syndrome Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Brugada Syndrome Market Size Market Share by Region (2017-2022)
Table 26. APAC Brugada Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Brugada Syndrome Market Size Market Share by Type (2017-2022)
Table 28. APAC Brugada Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Brugada Syndrome Market Size Market Share by Application (2017-2022)
Table 30. Europe Brugada Syndrome Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Brugada Syndrome Market Size Market Share by Country (2017-2022)
Table 32. Europe Brugada Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Brugada Syndrome Market Size Market Share by Type (2017-2022)
Table 34. Europe Brugada Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Brugada Syndrome Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Brugada Syndrome Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Brugada Syndrome Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Brugada Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Brugada Syndrome Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Brugada Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Brugada Syndrome Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Brugada Syndrome
Table 43. Key Market Challenges & Risks of Brugada Syndrome
Table 44. Key Industry Trends of Brugada Syndrome
Table 45. Global Brugada Syndrome Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Brugada Syndrome Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Brugada Syndrome Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Brugada Syndrome Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Brugada Syndrome Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Brugada Syndrome Market Size Market Share Forecast by Application (2023-2028)
Table 51. GeneDx Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 52. GeneDx Brugada Syndrome Product Offered
Table 53. GeneDx Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. GeneDx Main Business
Table 55. GeneDx Latest Developments
Table 56. PGxHealth Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 57. PGxHealth Brugada Syndrome Product Offered
Table 58. PGxHealth Main Business
Table 59. PGxHealth Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. PGxHealth Latest Developments
Table 61. GE Healthcare Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 62. GE Healthcare Brugada Syndrome Product Offered
Table 63. GE Healthcare Main Business
Table 64. GE Healthcare Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. GE Healthcare Latest Developments
Table 66. Pfizer Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 67. Pfizer Brugada Syndrome Product Offered
Table 68. Pfizer Main Business
Table 69. Pfizer Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Pfizer Latest Developments
Table 71. Abbott Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 72. Abbott Brugada Syndrome Product Offered
Table 73. Abbott Main Business
Table 74. Abbott Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Abbott Latest Developments
Table 76. Medtronic Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 77. Medtronic Brugada Syndrome Product Offered
Table 78. Medtronic Main Business
Table 79. Medtronic Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Medtronic Latest Developments
Table 81. Boston Scientific Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 82. Boston Scientific Brugada Syndrome Product Offered
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Boston Scientific Latest Developments
Table 86. GlaxoSmithKline Details, Company Type, Brugada Syndrome Area Served and Its Competitors
Table 87. GlaxoSmithKline Brugada Syndrome Product Offered
Table 88. GlaxoSmithKline Main Business
Table 89. GlaxoSmithKline Brugada Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Brugada Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Brugada Syndrome Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Brugada Syndrome Market Size Market Share by Type in 2021
Figure 7. Brugada Syndrome in Adult
Figure 8. Global Brugada Syndrome Market: Adult (2017-2022) & ($ Millions)
Figure 9. Brugada Syndrome in Child
Figure 10. Global Brugada Syndrome Market: Child (2017-2022) & ($ Millions)
Figure 11. Global Brugada Syndrome Market Size Market Share by Application in 2021
Figure 12. Global Brugada Syndrome Revenue Market Share by Player in 2021
Figure 13. Global Brugada Syndrome Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Brugada Syndrome Market Size 2017-2022 ($ Millions)
Figure 15. APAC Brugada Syndrome Market Size 2017-2022 ($ Millions)
Figure 16. Europe Brugada Syndrome Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Brugada Syndrome Market Size 2017-2022 ($ Millions)
Figure 18. Americas Brugada Syndrome Value Market Share by Country in 2021
Figure 19. Americas Brugada Syndrome Consumption Market Share by Type in 2021
Figure 20. Americas Brugada Syndrome Market Size Market Share by Application in 2021
Figure 21. United States Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Brugada Syndrome Market Size Market Share by Region in 2021
Figure 26. APAC Brugada Syndrome Market Size Market Share by Application in 2021
Figure 27. China Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Brugada Syndrome Market Size Market Share by Country in 2021
Figure 34. Europe Brugada Syndrome Market Size Market Share by Type in 2021
Figure 35. Europe Brugada Syndrome Market Size Market Share by Application in 2021
Figure 36. Germany Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Brugada Syndrome Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Brugada Syndrome Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Brugada Syndrome Market Size Market Share by Application in 2021
Figure 44. Egypt Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Brugada Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 50. APAC Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 51. Europe Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 53. United States Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 54. Canada Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 57. China Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 58. Japan Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 59. Korea Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 61. India Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 62. Australia Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 63. Germany Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 64. France Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 65. UK Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 66. Italy Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 67. Russia Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 68. Spain Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 71. Israel Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Brugada Syndrome Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Brugada Syndrome Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
